"Obesity medications get no respect," says Thomas Wadden, director of the University of Pennsylvania's Weight and Eating Disorders Program, who has consulted with Sanofi-Aventis about Acomplia (rimonabant).
Talking about lack of insurance reimbursment for anti-obesity drugs he goes on to say: "There would be a lot more people on the medications if they were reimbursed - $100 a month out-of-pocket forces some people to choose between their car payment or their weight-loss drug."
Insiders' view: The good doctor might just have accidentally revealed how much Sanofi-Aventis are planning to charge for their great new hope (still to be approved).......
As for respect, well Insiders' view is that respect is earned, it's not just a free handout!
Source: Timesleader.com
No comments:
Post a Comment